Abstract
We describe a method for the purification of recombinant proteins based upon the selective interaction of the choline–binding domain of the pneumococcal murein hydrolase and tertiary amines. Proteins of interest, fused to the binding domain by a peptide linker, containing the cleaving sequence recognized by blood coagulation factor Xa, can either be assayed for biological activities in vitro and in vivo or have the binding moiety removed to yield a totally unmodified form, suitable for clinical and functional studies. The method can also be applied to the production of low molecular mass peptides. The principle of the technique is illustrated with acidic fibro–blast growth factor and with a neuropeptide–like fragment of ten amino acids contained within its sequence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ben Bassat, A. and Bauer, K. 1987. Amino-terminal processing of proteins. Nature 326.
Hochuli, E., Bannwarth, W., Dòbeli, H., Gentz, R. and Stüber, D. 1988. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelatc adsorbent. Bio/Technology 6: 1321–1325.
Smith, M.C., Thomas, C.F., Ingolia, T.D. and Pidgeon, C. 1988. Chelating peptide-immobilized metal ion affinity chromatography. J. Biol. Chem. 263: 7211–7215
Thomas, K.A. and Giménez-Gallego, G. 1986. Fibroblast growth factors: broad spectrum mitogens with potent angiogcnic activity. Trends in Biochem. Sci. 11: 1–4.
Cuevas, P., Carceller, F., Ortega, S., Zazo, M., Nieto, I. and Giménez Gallego, G. 1991. Hypotensive activity of fibroblast growth factor. Science 254: 1208–1210
Linemeyer, D.L., Kelly, L.J., Menke, J.G., Giménez-Gallego, G., DiSalvo, J. and Thomas, K.A. 1987. Expression in Escherichia coli of a chemically synthesized gene for biologically active bovine acidic fibroblast growth factor. Bio/Technology 5: 960–965.
Jaye, M., Burgess, W.H., Shaw, A.B. and Drohan, W.N. 1987. Biological equivalence of natural bovine and recombinant human α-endothelial cell growth factors. J. Biol. Chem. 262: 16612–16617.
Burgess, W.H., Shaheen, A.M., Ravera, M., Jaye, M., Donohue, J. and Winkles, J.A. 1990. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J. Cell Biol. 111: 2129–2138.
Sánchez-Puelles, J.M., Sanz, J.M., Garcìa, J.L. and Carcía, E. 1990. Cloning and expression of gene fragments encoding the choline-binding domain of pneumococcal murein hydrolases. Gene 89: 69–75.
Sanz, J.M., López, R. and García, J.L. 1988. Structural requirements of choline derivatives for “conversion” of pneumococcal amidase. A new single-step procedure for purification of this autolysin. FEBS Lett. 232: 308–312.
Giménez Gallego, G., Rodkey, J., Bennett, C., Rios-Candelore, M., DiSalvo, J. and Thomas, K. 1985. Brain-derived acidic fibroblast growth factor: Complete amino acid sequence and homologies. Science 230: 1385–1388.
Masui, Y., Coleman, J. and Inouye, M. 1983. Multipurpose expression cloning vehicles in Escherichia coli, p. 15–32. In: Experimental Manipulation of Gene Expression. M. Inouye (Ed.). Academic Press, New York.
Zazo, M., Lozano, R.M., Ortega, S., Varela, J., Díaz-Orejas, R., Ramírez, J.M. and Giménez-Gailego, G. 1992. High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and its purification in a form stable in aqueous solutions. Gene In Press.
Sánchez-Puclles, J.M., García, J.L., López, R. and García, E. 1987. 3′-End modifications of the Streptococcus pneumnniae lytA gene: role of the carboxy terminus of the pneumococcal autolysin in the process of enzymatic activation (conversion). Gene 61: 13–19.
Gospodarowicz, D. and Cheng, J. 1986. Heparin protects basic and acidic FGF from inactivation. J. Cell Physiol. 128: 475–484.
Ortega, S., Schaeffer, M.-T., Soderman, D., DiSalvo, J., Linemeyer, D.L., Giménez-Gallego, G. and Thomas, K.A. 1991. Conversion of cysteine to serine residues alters the activity, stability and heparin dependence of acidic fibroblast growth factor. J. Biol Chem. 266: 5842–5846.
Sambrook, J., Fritsch, E.F. and Maniatis, T. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
Sanger, F., Nicklen, S. and Coulson, A.R. 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ortega, S., García, J., Zazo, M. et al. Single–Step Purification on DEAE–Sephacel of Recombinant Polypeptides Produced in Escherichia Coli. Nat Biotechnol 10, 795–798 (1992). https://doi.org/10.1038/nbt0792-795
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0792-795